Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11351232 Albumin-free botulinum toxin formulations

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
‌
Revance Therapeutics, Inc.
Date Filed
October 30, 2018
Date of Patent
June 7, 2022
Patent Applicant
‌
Revance Therapeutics, Inc.
Patent Application Number
16175434
Patent Citations
‌
US Patent 10201594 Compositions and methods for safe treatment of rhinitis
‌
US Patent 10285941 Amphiphilic entity nanoparticles
‌
US Patent 10549042 Botulinum toxin prefilled glass syringe
‌
US Patent 10576034 Botulinum nanoemulsions
‌
US Patent 10561604 Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose
‌
US Patent 10744078 Compositions and methods for topical application and transdermal delivery of botulinum toxins
‌
US Patent 10080786 Methods for treating pain by topical application and transdermal delivery of botulinum toxin
‌
US Patent 10105421 Therapeutic composition with a botulinum neurotoxin
‌
US Patent 10111939 Albumin-free botulinum toxin formulations
‌
US Patent 10172877 Compositions and methods for topical diagnostic and therapeutic transport
Patent Citations Received
‌
US Patent 11680087 None
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11351232
Patent Primary Examiner
‌
Nita M. Minnifield

Find more entities like US Patent 11351232 Albumin-free botulinum toxin formulations

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo